While Lees-Shepard et al. observed that Pdgfrα+ cells contributed to heterotopic ossification (HO) in their model, it is not known whether this specific cell population is clinically relevant in FOP patients. The gene discussed is PDGFRA; the disease is fibrodysplasia ossificans progressiva.